Daniel Donovan - 15 Jun 2022 Form 3 Insider Report for Panbela Therapeutics, Inc. (PBLA)

Reporting relationship
Director
Issuer ticker
PBLA
Reported as of
15 Jun 2022
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
24 Jun 2022, 16:46:58 UTC
Next SEC filing
29 Mar 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Joshua L. Colburn, Attorney-in-Fact

Key filing fact

Daniel Donovan filed Form 3 for Panbela Therapeutics, Inc. (PBLA) on 24 Jun 2022.

Key facts

  • This page summarizes Daniel Donovan's Form 3 filing for Panbela Therapeutics, Inc. (PBLA).
  • 0 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 24 Jun 2022, 16:46.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PBLA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
71,535
Date
15 Jun 2022
Ownership
Direct
PBLA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
163,256
Date
15 Jun 2022
Ownership
By GDB Investments, LLP
Footnotes
F1
PBLA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
75,528
Date
15 Jun 2022
Ownership
By Westport Boys, LLC
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PBLA holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
15 Jun 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
37,320
Exercise price
$0.2200
Footnotes
F2
PBLA holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
15 Jun 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
22,214
Exercise price
$0.2200
Footnotes
F2
PBLA holding Derivative

Warrants (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
15 Jun 2022
Ownership
By GDB Investments, LLP
Underlying class
Common Stock
Underlying amount
5,183
Exercise price
$6.76
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Footnote F2

Fully vested.

SEC remarks

Exhibit List: Power of Attorney EX-24

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .